Following an initial analysis, AnimalhealthEurope is pleased to see the importance of animal health given a priority focus in the proposed blueprint for the UK’s exit from the EU.
“The animal medicines sector in Europe notes with interest the recognition of the importance of our manufacturing sector and the mention of ‘bespoke provisions for animal medicines’ in the Brexit whitepaper. The clear acknowledgement of the ‘unique status’ of our products and their benefits is good news for the future supply of animal health products, animal welfare and food security across the European region. Alignment with EU rules on animal health and welfare can help ensure a minimum disruption to trade and increase certainty for both the animal medicines industry and the sectors our products support.”
“The animal medicines sector is ready and willing to provide information as necessary for upcoming negotiations to ensure the best possible outcome for the future, for Europe’s animals, vets, farmers and pet owners as well as for the future of the animal medicines industry”, commented Roxane Feller, AnimalhealthEurope Secretary General